PERTH, AUSTRALIA: September 12, 2012 – Phylogica Ltd (ASX:PYC, XETRA: PH7), a leading Australian peptide drug discovery company, has licensed its skin-repair Phylomer peptide PYC35 to Le Métier de Beauté for use in cosmetic products in the US, UK and Hong Kong markets.
Le Métier will use PYC35 in its premium range of Peau Vierge anti-aging creams that will be commercialised initially across the US through department stores such as Neiman Marcus, Bergdorf Goodman and Nordstrom. Le Métier is responsible for all future costs including formulation, manufacturing and marketing.
Under the terms of the agreement Phylogica will receive a significant royalty on all sales of Le Métier’s cosmetic products that contain PYC35. Phylogica retains all pharmaceutical rights to PYC35.
The Phylomer peptide PYC35 derives from the genome of a microorganism known as Pyrococcus horikoshii, that belongs to an ancient kingdom of life that evolved billions of years ago. This thermophilic species dwells in undersea volcanic vents and can endure extreme environmental conditions such as high pressure and high temperature. In these environments the pressure is about 200 atmospheres with temperatures of nearly 100°C.
For further information please download PDF below:
